drugset / Trial / NCT05393856
CG-549 Tablet Pharmacokinetics Study
RandomizedCrossoverOpen-labelTreatment
Summary
This will be an open label, crossover, single dose study consisting of 2 parts (Part A and Part B) in a total of 24 healthy male and female subjects.
Timeline
- Start
- 2019-09-23
- Primary completion
- 2020-01-20
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CG-549 | Unknown | 300 mg | Oral |
Indications
No indication recorded.